Migration of cultured chimpanzee dendritic cells following intravenous and subcutaneous injection

Advances in Experimental Medicine and Biology

Volumn 417, Issue , 1997, Pages 71-75

  Barratt Boyes, Simon M ^a   Watkins, Simon C ^b   Finn, Olivera J ^a,c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; CELL MIGRATION; CELL MOTILITY; CELL TRANSPLANTATION; CHIMPANZEE; CONFERENCE PAPER; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; IMMUNOTHERAPY; LYMPH NODE; PRIORITY JOURNAL;

ANIMALIA; PAN TROGLODYTES;

EID: 0030868525     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4757-9966-8_12     Document Type: Conference Paper

References (16)

1. Grabbe S, Biessert S, Schwarz T, Granstein RD (1995). Dendritic cells as initiators of tumor immune responses: a possible strategy for tumor immunotherapy? Immunol Today 16, 117-121.
2. Steinman RM (1991). The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 9, 271-296.
3. Caux C, Dezutter-Dambuyant C, Schmitt D, Banchereau J (1992). GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells. Nature 360, 258-261.
4. Sallusto F, Lanzavecchia A (1994). Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor a. J Exp Med 179, 1109-1118.
5. Mayordomo JI, Zorina T, Storkus WJ, Zitvogel L, Celluzzi C, Falo LD, Melief CJ, Ildstad ST. Kast WM, DeLeo AB, Lotze ML (1995). Bone marrow-derived dendritic cells pulsed with synthetic tumor peptides elicit protective and therapeutic antitumor immunity. Nature Med 1, 1297-1302.
6. Hsu FJ, Benike C, Fagnoni F, Liles TM, Czerwinski D, Taidi B, Engleman EG, Levy R (1996). Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nature Med 2, 52-58.
7. Austyn JM, Larsen CP (1990). Migration patterns of dendritic leukocytes. Transplantation 49, 1-7.
8. Macatonia SE, Edwards AJ, Knight SC (1986). Dendritic cells and contact sensitivity to fluorescein isothiocyanate. Immunology 59, 509-514.
9. Fossum S (1988). Lymph-borne dendritic leukocytes do not recirculate, but enter the lymph node paracortex to become interdigitating cells. Scand J Immunol 27, 97-105.
10. Kupiec-Weglinski JW, Austyn JM, Morris PJ (1988). Migration patterns of dendritic cells in the mouse: Traffic from the blood, and T cell-dependent and independent entry to lymphoid tissues. J Exp Med 167, 632-645.
11. Barratt-Boyes SM, Henderson RA, Finn OJ (1996). Chimpanzee dendritic cells with potent immunostimulatory function can be propagated from peripheral blood. Immunology 87, 528-534.
12. Roake JA, Rao AS, Morris PJ, Larsen CP, Hankins DF, Austyn JM (1995). Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1. J Exp Med 181, 2237-2247.
13. Ma J, Wang J-H, Guo Y-J, Sy M-S, Bigby M (1994). In vivo treatment with anti-ICAM-I and anti-LFA-1 antibodies inhibits contact sensitization-induced migration of epidermal Langerhans cells to regional lymph nodes. Cell Immunol 158, 389-399.
14. Henderson RA, Nimgoankar MT, Watkins SC, Robbins PD, Ball ED, Finn OJ (1996). Human dendritic cells genetically engineered to express high levels of the human epithelial tumor antigen mucin (MUC-1). Cancer Res 56, 3763-3770.
15. Austyn JM, Kupiec-Weglinski JW, Hankins DF, Morris PJ (1988). Migration patterns of dendritic cells in the mouse: Homing to T cell-dependent areas of spleen, and binding within marginal zone. J Exp Med 167, 646-651.
16. Morikawa Y, Furotani M, Kuribayashi K, Matsuura N, Kakudo K (1992). The role of antigen-presenting cells in the regulation of delayed-type hypersensitivity. I. Spleen dendritic cells. Immunology 77, 81-87.